biodexapharma.com (BDRX): Projected Price to Earnings

BDRX (Biodexa Pharmaceuticals PLC) - company brandmark

Biodexa Pharmaceuticals (BDRX) is currently focusing on the commercialization of existing assets, temporarily stepping away from major mergers. The company's forward P/E ratio clearly demonstrates the impact of this strategy, with the indicator reaching 0.00. Business revenues are based on the development of targeted drugs for rare tumors. The current share price depends directly on patent protection and FDA verdicts regarding new therapy methods.

BDRX - Biodexa Pharmaceuticals Future Price to Earnings over the range 04/28/2023 - 11/15/2026

Summary analytical data breakdowns for Biodexa Pharmaceuticals (BDRX)

- stock quotes and analyst forecast:
Stock Price Biodexa|BDRX - Consensus Target
- stock exchange capitalization data:
Market Valuation Biodexa|BDRX - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Biodexa Pharmaceuticals|BDRX - Company Book Value|Market Capitalization to Book Value Ratio biodexapharma.com|BDRX - Company Total Asset Base
- debt level and financial liquidity data:
Debt to Equity Biodexa Pharmaceuticals|BDRX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Biodexa Pharma|BDRX - Company Aggregate Debt|Debts to Book Capitalization Biodexa|BDRX - Long-Term Debt|Company Current Liabilities Biodexa Pharmaceuticals|Quick Ratio biodexapharma.com
- earnings and market ratios statistics:
BDRX - Net Profit|Future Profit Biodexa Pharmaceuticals|BDRX - Company Value to Net Income|Future Price to Earnings biodexapharma.com|BDRX - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Biodexa Pharmaceuticals|BDRX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Biodexa Pharmaceuticals|BDRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months biodexapharma.com|BDRX - Earnings per share increase in current year|Net earnings per share growth forecast for next year Biodexa Pharmaceuticals
- issuer revenue and sales details:
BDRX - Company Sales|Projected Sales Volume biodexapharma.com|BDRX - P/S Multiple|Forward P/S Multiple Biodexa Pharmaceuticals
Summary company analytics:Biodexa Pharmaceuticals PLC
Signature product of Biodexa Pharma

The stability of the scientific core of Biodexa Pharmaceuticals (BDRX) in the field of drug delivery systems is reflected in the forward P/E dynamics of the issuer on the GURU.Markets platform, where market expectations are weighed against projected earnings. This indicator measures the cost per unit of expected income, allowing investors to determine the extent of the premium paid for future growth and assess the actual margin of safety for the investment.

Competitors of Biodexa Pharmaceuticals (BDRX)

Projected Price to Earnings CVS (CVS Health Corporation)|MCK - Projected Price to Earnings Ratio|Forward P/E Multiple COR (cencora.com)|CAH - Projected Price to Earnings|Henry Schein - Forward P/E Multiple|Future Price to Earnings Multiple PBH (Prestige Consumer Healthcare, Inc.)|WGRX: Forward P/E Multiple|YI (111.com.cn) - Future Price to Earnings|RDGT (jiuzhou360.com) - Forward P/E Multiple|Future Price to Earnings UPC|Forward P/E Multiple HKPD|Market Cap to Projected Earnings BIMI International Medical|Forward P/E Multiple CJJD (China Jo-Jo Drugstores Inc.)|Walgreens (WBA) - Projected Price to Earnings Ratio